+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Epzicom"

HIV Drugs Market Analysis & Forecast to 2024-2034 - Product Thumbnail Image

HIV Drugs Market Analysis & Forecast to 2024-2034

  • Report
  • January 2024
  • 200 Pages
  • Global
From
Epzicom - API Insight, 2022 - Product Thumbnail Image

Epzicom - API Insight, 2022

  • Drug Pipelines
  • January 2022
  • 30 Pages
  • Global
From
HIV Drugs Market By Medication Class, By Distribution Channel: Global Opportunity Analysis and Industry Forecast, 2023-2032 - Product Thumbnail Image

HIV Drugs Market By Medication Class, By Distribution Channel: Global Opportunity Analysis and Industry Forecast, 2023-2032

  • Report
  • November 2023
  • 35 Pages
  • Global
From
  • 3 Results (Page 1 of 1)
Loading Indicator

Epzicom is a market of HIV/AIDS drugs, specifically a combination of two antiretroviral drugs, abacavir and lamivudine. It is used to treat HIV-1 infection in adults and children over the age of three months. The combination of these two drugs helps to reduce the amount of HIV in the body, allowing the immune system to recover and fight off infections. Epzicom is also used to reduce the risk of HIV transmission from mother to child during pregnancy. Epzicom is a widely used HIV/AIDS drug, with many companies producing and distributing it. Some of these companies include GlaxoSmithKline, Bristol-Myers Squibb, Merck, and Gilead Sciences. Show Less Read more